LncRNA SNHG12 promotes the malignant progression of melanoma by targeting miR-199b

被引:0
|
作者
Xie, Yijie [1 ]
Chen, Guangxiong [1 ]
机构
[1] Ningbo Univ, Affiliated Peoples Hosp, Dept Dermatol, Ningbo 315040, Zhejiang, Peoples R China
关键词
Melanoma; lncRNA; SNHG12; miR-199b; CELL-PROLIFERATION; BREAST-CANCER; MIGRATION; INVASION;
D O I
10.21037/atm-22-214
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Melanoma is a type of tumor caused by the malignant transformation of melanocytes, and has a high degree of malignancy. Small nucleolar RNA host gene 12 (SNHG12) plays an important role in a variety of cancers, but its role in melanoma and its mechanisms are still unclear. In this study, we measured the expression of SNHG12 and explored the molecular mechanisms involved in melanoma. Methods: We detected the expression level of SNHG12 in melanoma cell lines, and explored the effect of SNHG12 on the proliferation, migration, and invasion of melanoma cells in vitro. Mechanistic studies explored the regulation of downstream genes by SNHG12. Results: Overexpression of SNHG12 was found in melanoma cell lines, and SNHG12 promoted the proliferation, migration, and invasion of melanoma cells. MiR-199b is a target gene of SNHG12, which was expressed at low levels in melanoma cell lines, and SNHG12 regulated melanoma cell proliferation, migration, and invasion through miR-199b. We also revealed that SNHG12 promoted the expression of the target genes of miR-199b, namely ETS1, PXN,JAG1, and DDR1. Conclusions: SNHG12 is highly expressed in melanoma, and promotes the expression of ETS1, PXN, JAG1, and DDR1 through targeted regulation of miR-199b, thereby promoting the proliferation, migration, and invasion of melanoma cells.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Knockdown of lncRNA SNHG12 suppresses cell proliferation, migration and invasion in breast cancer by sponging miR-451a
    Dong, Yi
    Wang, Gangle
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (03): : 393 - 402
  • [32] LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A
    Fan, Xiaoxi
    Zhao, Zhongwei
    Song, Jingjing
    Zhang, Dengke
    Wu, Fazong
    Tu, Jianfei
    Xu, Min
    Ji, Jiansong
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [33] miR-199a和lncRNA SNHG12在宫颈癌中的表达水平、相关性及临床意义
    徐勇飞
    温媛媛
    金丹雯
    钱立勇
    许辉
    刘海青
    中国妇幼保健, 2020, 35 (11) : 2090 - 2094
  • [34] MiR-199b represses porcine muscle satellite cells proliferation by targeting JAG1
    Zhu, Linhui
    Hou, Lianjie
    Ou, Jinxin
    Xu, Guli
    Jiang, Fangyi
    Hu, Chingyuan
    Wang, Chong
    GENE, 2019, 691 : 24 - 33
  • [35] LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A
    Xiaoxi Fan
    Zhongwei Zhao
    Jingjing Song
    Dengke Zhang
    Fazong Wu
    Jianfei Tu
    Min Xu
    Jiansong Ji
    Cancer Cell International, 21
  • [36] LncRNA SNHG12 Regulates Vascular Senescence and Atherosclerosis by Targeting A DNA-PK-Mediated DNA Damage Response
    Haemmig, Stefan
    Yang Dafeng
    Das, Debapria
    Ghaffari, Siavash
    Deng Yihuan
    Chen Lei
    Sun Xinghui
    Moullan, Norman
    Tesmenitsky, Yevgenia
    Wara, A. K. M. Khyrul
    Shvartz, Eugenia
    Sukova, Galina
    Marto, Jarrod A.
    Stone, Peter H.
    Lee, Warren L.
    Auwerx, Johan
    Libby, Peter
    Feinberg, Mark W.
    CIRCULATION, 2018, 138
  • [37] 血浆lncRNA SNHG12、miR-133b预测乳腺癌新辅助治疗效果的价值
    高雪原
    刘家麒
    陈洁清
    程学远
    检验医学与临床, 2024, 21 (20) : 2951 - 2957
  • [38] Long noncoding RNA SNHG10 promotes colorectal cancer cells malignant progression by targeting miR-3690
    Zhang, Hao
    Fang, Zhenghua
    Guo, Yesong
    Wang, Dejun
    BIOENGINEERED, 2021, 12 (01) : 6010 - 6020
  • [39] MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2
    Chen, Zi
    Zhao, Guohui
    Zhang, Yunkun
    Ma, Yong
    Ding, Yin
    Xu, Nanwei
    JOURNAL OF BUON, 2018, 23 (06): : 1816 - 1824
  • [40] LncRNA NORAD promotes thyroid carcinoma progression by targeting miR-451
    Shi, L.
    Cong, Y. -Z.
    Wang, Z. -J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (20) : 6187 - 6195